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Distraction osteogenesis through an externally applied fixator 
is a well-established treatment for lower limb lengthening (De 
Bastiani et al. 1987, Paley 1988, Ilizarov 1990). However, com-
plication rates of this treatment are high, amounting to 1–3.2 
complications per patient (Tjernström et al. 1994, Noonan et 
al. 1998). The wires or pins penetrating soft tissues result in 
complications such as pin site infection, pain, scarring, muscle 
transfixation, reduced joint movement, and immobility (Paley 
1990, Mazeau et al. 2012, Landge et al. 2015). When the 
external fixator is removed, there is a risk of further complica-
tions such as fracture or malalignment (Noonan et al. 1998, 
Simpson and Kenwright 2000). To reduce complications and 
improve patient comfort, limb lengthening by fully implant-
able bone lengthening nails has been introduced (Guichet 
1999, Cole et al. 2001). Problems with purely mechanically 
driven lengthening nails were resolved by the introduction of 
motorized (FITBONE) or magnetically driven (PRECICE) 
bone lengthening nails (Baumgart et al. 1997, Kirane et al. 
2014, Paley et al. 2014, Shabtai et al. 2014). A few case-con-
trol studies have compared these nails with external fixation 
(13–15 patients), and the largest case series on intramedullary 
bone lengthening reports on 92 patients (Black et al. 2015, 
Horn et al. 2015, Calder et al. 2019). However, the majority 
of reports of complications of the FITBONE and PRECICE 
lengthening nails are small case series (Krieg et al. 2008, Din-
çyürek et al. 2012, Birkholtz and De-Lange 2016, Hammouda 
et al. 2017). In recent years motorized intramedullary length-
ening nails have become increasingly popular, and we thus 
hypothesized that standardized data on complications could 
now be extracted from the literature. We performed a system-
atic literature review of complications using PRECICE and 
FITBONE bone lengthening nails in lower limb bone length-
ening. The primary outcome was risk of complications impos-
ing a new pathology or permanent sequelae in the patient. 
Background and purpose — In recent years motorized 
intramedullary lengthening nails have become increasingly 
popular. Complications are heterogeneously reported in 
small case series and therefore we made a systematic review 
of complications occurring in lower limb lengthening with 
externally controlled motorized intramedullary bone length-
ening nails.
Methods — We performed a systematic search in 
PubMed, EMBASE, and the Cochrane Library with medical 
subject headings: Bone Nails, Bone Lengthening, and PRE-
CICE and FITBONE nails. Complications were graded on 
severity and origin.
Results — The search identified 952 articles; 116 were 
full text screened, and 41 were included in the final analy-
sis. 983 segments were lengthened in 782 patients (age 8–74 
years). The distribution of nails was: 214 FITBONE, 747 
PRECICE, 22 either FITBONE or PRECICE. Indications for 
lengthening were: 208 congenital shortening, 305 acquired 
limb shortening, 111 short stature, 158 with unidentified eti-
ology. We identified 332 complications (34% of segments): 
Type I (minimal intervention) in 11% of segments; Type II 
(substantial change in treatment plan) in 15% of segments; 
Type IIIA (failure to achieve goal) in 5% of segments; and 
Type IIIB (new pathology or permanent sequelae) in 3% of 
segments. Device and bone complications were the most fre-
quent.
Interpretation — The overall risk of complications was 1 
complication for every 3 segments lengthened. In 1 of every 
4 segments, complications had a major impact leading to 
substantial change in treatment, failure to achieve length-
ening goal, introduction of a new pathology, or permanent 
sequelae. However, as no standardized reporting method for 
complications exists, the true complication rates might be 
different.
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Method
Search criteria
An electronic search in the databases PubMed, Embase, and 
Cochrane Library was performed by a health science librarian 
with expertise in systematic literature searching. For details of 
the search strategy see Supplementary data 1. There was no 
limit concerning study design, publishing date, or language. 
We searched reference lists of included studies, relevant 
reviews identified through the systematic search and authors’ 
personal files to ensure literature saturation. 
Inclusion and exclusion criteria
We included only published full-text original studies designed 
as randomized controlled trials, prospective and retrospec-
tive cohort studies, case-control studies, case series, and case 
reports. Cross-sectional studies were excluded. Studies in both 
English and German were included.
Studies were included if: the bone lengthening nails applied 
were FITBONE (Wittenstein Intens GmbH, Igersheim, Ger-
many) and/or PRECICE (Nuvasive, San Diego, CA, USA), 
conducted in humans, and bone lengthening was performed 
on lower extremities. Descriptions of complications included 
origin, severity, and management of complications or a state-
ment of no complications. Studies were excluded if: reporting 
only bone transport treatment, nails were used only for com-
pression, there was no involvement of lower extremities, or 
reporting stump lengthening. If patients were represented in 
more than one study, only one of the studies was included. A 
single patient or a group of patients from one study could be 
included if patient-/group-specific data was available. 
Data collection and management 
The primary search was performed at the end of November 
2019 and updated at the end of March 2020. The literature 
search was assembled in www.covidence.org as well as the 
management of article selection flow. Titles and abstracts 
were screened by the first author (MWF) to select articles for 
full text reading. Among the full text articles, MWF selected 
papers for possible inclusion. SK and MWF assessed articles 
in accordance with inclusion criteria and agreed on studies rel-
evant for final inclusion. 
During the initial data collection, MWF collected the fol-
lowing information from each study: title, author(s), year of 
publication, study design, evidence level, number of patients, 
number of lengthening segments, sex, nail type (FITBONE or 
PRECICE), participant age range, and bone segments (femur 
or tibia). Etiology was divided into 3 groups: (1) congenital, 
(2) short stature, (3) acquired/developed limb length discrep-
ancy diagnoses in accordance with the modified Stricker and 
Hunt classification (Stricker and Hunt 2004) (see Supplemen-
tary data 2), min./max. leg length, and perioperative soft tissue 
release. Complications were assessed according to the particu-
lar point in time when they occurred: intraoperative complica-
tion (Early 1:E1), postoperative complication prior to distrac-
tion start (Early 2:E2), during distraction period (Late 1:L1), 
after end of distraction and prior to implant removal (Late 
2:L2), and after implant removal (Late 3:L3) (see Supple-
mentary data 3). The severity of complications was classified 
Table 1. Classification of severity of complications in accordance with Black et al. and Paley
  Complication severity grade
   Modified Black et al. 2015 Paley 1990   Examples of complications  
   I Minimal intervention required;  Problems Potential expected difficulty arising Pin-site infection. Temporary joint
 treatment goal still achieved  during distraction or fixation period contracture 
   which is fully resolved non-operatively 
   by end of the treatment period
  II Substantial change in treatment Obstacle  Potential expected difficulty that arose Unplanned return to surgery, such
 plan; treatment goal still achieved  doing distraction or fixation period that as delayed consolidation requiring 
   is fully resolved by end of the treatment additional intervention, and device 
   period by operative means problem needing revision
IIIA Failure to achieve treatment goal; Complication Complication include any local or 
 no new pathology or permanent  systemic intraoperative or perioperative  Premature consolidation with
 sequelae. Peri- or intraoperative   complication, difficulty during distraction aborted lengthening, inability to
 complication without sequelae  or fixation that remains unsolved at the tolerate lengthening, and fracture
   end of treatment period, and any early at fixation site or regenerate bone 
   or late post-treatment difficulty with shortening 
IIIB Failure to achieve treatment goal  Complications were divided into minor  Joint subluxation, joint dislocation,
 and/or new pathology or   and major depending on whether the  regenerate fracture with deformity,
 permanent sequelae  original treatment goal was achieved  and deep infection.
    Thromboembolic complication
    such as deep vein thrombosis
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according to Black et al. (2015) (Table 1). If a complication 
was graded according to Paley, we used Table 1 to compile 
the complication into the Black classification. If the treatment 
of a complication was not thoroughly described, we generally 
downgraded it, assuming that the treatment goal was achieved 
and no new pathology or permanent sequalae had emerged. 
As an example, a joint contracture with no described changes 
in treatment was classified as grade I. If a complication was 
graded by article authors as grade I, but the described treat-
ment included additional surgery, we graded it as grade II. 
A deep vein thrombosis was graded as grade IIIB. The type 
of complication was categorized into origin representing 8 
main groups (soft tissue, joint, vascular, bone, neurological, 
infection, device-related, others) and 33 subgroups according 
to Table 5 (for specific examples see Supplementary data 4). 
Intra-articular nail placement causing irritation and residual 
deformity was categorized into origin as Others/Surgical. 
Patient requesting to stop the lengthening procedure was cat-
egorized into origin as Others/Patient. 
MWF identified all complications and graded them accord-
ing to severity, time of treatment, and origin. A second 
reviewer (SK) subsequently evaluated and graded the compli-
cation concerning severity and origin. Disagreement between 
reviewers was solved by consensus discussion.
The Oxford Centre for Evidence-Based Medicine—Levels 
of Evidence 2009 grading of Harm was used to assess the 
level of evidence in the included studies (case reports were not 
included). A study was classified as a case report if reporting 
less than 5 bone lengthening segments. Case series with a sub-
group analysis were classified as a cohort study. A study was 
considered prospective if data were collected prospectively; 
all other studies were considered retrospective. 
We used a methodology quality assessment score for all 
studies: Methodological Index for Non-Randomized Stud-
ies (MINORS) for non-randomized studies; Murad et al. for 
case reports (Slim et al. 2003, Murad et al. 2018). MWF and 
AG independently assessed the studies and solved difference 
through discussion. 3 specific questions concerning harms 
(from the McHarm scale) were used (Santaguida et al. 2011, 
Kronick et al. 2014) (see methodology quality assessment 
score, Supplementary data 5). 
Statistics
Microsoft Excel 2019 version 16.33 (Microsoft Corp, Red-
mond, WA, USA) was used for data storage and descrip-
tive analysis. Inter-rater agreement between the 2 assessors 
of complications was calculated as Kappa values for both 
severity grading of complications (4 types) and categori-
zation of origin (8 main groups and 33 sub-groups) with 
Stata/MP 15.1 (StataCorp, College Station, TX, USA). For 
the strength of agreement, values less than 0 were rated as 
Poor; 0–0.20 Slight; 0.21–0.40 Fair; 0.41–0.60 Moderate; 
0.61–0.8 Substantial; and 0.80–1 Almost perfect (Landis 
and Koch 1977). 
Registration, funding, and potential conflicts of interest
Prior to conducting the study, we searched the PROSPERO 
database (http://www.crd.york.ac.uk/PROSPERO) for ongo-
ing reviews and recently completed systematic reviews; we 
did not identify any results. This study was then submitted to 
PROSPERO on November 22, 2019. Due to waiting time at 
PROSPERO, this pre-study registration has unfortunately not 
been published before submission (April 23, 2020). During 
the review period, the pre-study registration was published by 
PROSPERO (ID number: CRD42020159272). The majority 
of studies included were case series and case reports and we 
changed the risk of bias/quality assessment tool to MINORS 
and added Murad et al. for case reports (Slim et al. 2003, 
Murad et al. 2018). Thus, reporting guidelines were also 
changed to Meta-analysis of Observational Studies in Epide-
miology (MOOSE), and this systematic review was organized 
in agreement with this (Stroup et al. 2000). The change was 
submitted to PROSPERO. The authors’ institutions funded the 
study. No conflicts of interest are declared.
Results
Our search identified 952 articles of which 41 were included 
(Table 2); for flowchart of article selection see Figure. There 
was 1 case-control study, 6 cohort studies, 26 case series, and 
8 case reports. Of the 33 studies that were not case reports, 
Flow diagram of selection of studies.
Studies identified through 
database searching (n = 831):
– Pubmed, 510
– Embase, 310
– Cochrane library, 11







Abstracts screened after duplicate removal
n = 622
Full-text articles assessed for eligibility
n = 116
Full-text articles excluded (n = 75):
– wrong publication types, 32
– other operation types, 16 
– other nail types, 11
– patients included in more than 1 study, 6
– wrong outcomes, 6 
– wrong indications, 3
– wrong study designs, 2
– insucient description of complications, 1
Studies included in qualitative synthesis (n = 41):
– case series, 26
– case reports, 8
– cohort studies, 6
– case-control study, 1   
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there was 1 level 3 study and 32 level 4 studies. The mean 
MINORS score was 8.3 (n = 26, range 5–12, ideal score 16) 
for non-comparative studies and 15.1 (n = 7, range 12–18, 
ideal score 24) for comparative studies (for full score of 
studies, see Supplementary data 6). The mean score for case 
reports was 4.3 (n = 8, 3–6 range, ideal score 8). Concerning 
the McHarm questions: (1) 1 study included predefined/stan-
dardized descriptions of complications, (2) standard scale of 
complications was used in 15 studies, and (3) number of each 
type of event and total number were specified on study groups 
in 31 studies (see Supplementary data 6).
The 41 studies included 782 patients and 983 bone length-
ening segments (Table 3). We found 332 complications cor-
responding to 34% of segments; 14 complications were not 
classified with origin, only severity. We observed 28 type IIIB 
complications, which was our primary outcome, correspond-
ing to 3% of segments. Type IIIA complications not achieving 
the lengthening goal were seen in 45 cases (5% of segments). 
There were 113 type I complications and 146 type II com-
plications, corresponding to 11% and 15% complications per 
segment, respectively (Table 4). Device-related complications 
(12% of segments) were the most frequent type of complica-
tion followed by bone (8% of segments) and then joint com-
plications (6% of segments) (Table 5).
5 studies reported a systematic approach to soft-tissue 
release during primary surgery (Shabtai et al. 2014, Paley et 
al. 2015, Laubscher et al. 2016, Rozbruch 2017, Calder et 
al. 2019). None of the 41 studies systematically reported the 
timing of the complication; in 332 complications, timing was 
established in 177 (53%) cases with 6 and 5 complications of 
E1 and E2, respectively. L1 and L2 were seen in 85 and 81 
cases, respectively and no L3 complications were found. In 18 
(8 of these were case reports) of the 41 studies, it was possible 
to connect the complication and the individual patient data. 
These 18 studies represent only 160 patients and we consid-
ered this number too low for subgroup analysis of complica-
Table 2. Included studies with the corresponding number of 
patients, segments, and complications used in this review
  Pro-  Seg-
  spec- Patients ments Nail Compli-
Reference tive n  n type a cations
Accadbled et al. 2019 Yes 5 7 F 1
Accadbled et al. 2016 Yes 23 26 F 9
Al-Sayyad 2012 Yes 10 14 F 1
Baumgart et al. 1997 No 11 11 F 6
Baumgart et al. 2005 No 1 3 F 0
Birkholtz and De-Lange 2016 No 9 11 P 2
Black et al. 2015 No 13 15 F 20
Calder et al. 2019 No 92 107 P 31
Cosic and Edwards 2020 No 21 21 P 9
Couto et al. 2018 No 1 2 P 0
Dinçyürek et al. 2012 No 14 15 F 12
Frommer et al. 2018 No 54 60 P 7
Haider and Wozasek 2019 No 20 20 P 8
Hammouda et al. 2017 No 17 17 P 4
Harkin et al. 2018 No 3 3 P 0
Havitcioglu et al. 2020 No 8 16 P/ F 4
Horn et al. 2019 No 47 50 P/ F 16
Iobst et al. 2018 No 27 27 P 4
Karakoyun et al. 2016 No 23 27 P 10
Karakoyun et al. 2015 No 22 22 F/P 2
Kariksiz and Karakoyun 2019 No 1 1 P 0
Kirane et al. 2014 No 24 25 P 6
Krieg et al. 2008 Yes 8 8 F 4
Krieg et al. 2011 No 32 32 F 10
Küçükkaya et al. 2015 No 22 25 F 5
Laubscher et al. 2016 No 15 20 P 5
Lee et al. 2017 No 41 80 P 36
Lenze et al. 2011 No 11 11 F 6
Morrison and Sontich 2016 No 1 1 P 1
Muratori et al. 2018 No 4 4 P 1
Nasto et al. 2020 Yes 26 26 P 10
Paley et al. 2015 No 51 116 P 20
Paley et al. 2014 No 46 62 P 31
Rozbruch 2017 No 2 2 P 1
Schiedel et al. 2014 Yes 24 26 P 9
Shabtai et al. 2014 Yes 18 21 P 9
Singh et al. 2006 No 10 24 F 14
Steiger et al. 2018 No 5 5 F 2
Tiefenboeck et al. 2016 No 10 10 P 13
Wiebking et al. 2016 No 9 9 P 2
Wu and Kuhn 2018 No 1 1 P 1
a F = FITBONE; P = PRECICE.
Table 3. Descriptive study data collected from the studies reporting 
group-level data 
   Studies
Factor Numbers reporting data
Number of patients 782 41
Number of bone segments 983 41
Male / female, n 384 / 234 29 / 33
Age, min / max 8 / 74 39
Etiology, n     
 Congenital disease 208 22
 Short stature 111 14
 Acquired/developmental LLD 305 29
Femur / tibia, n 813 / 170 40 / 28
Bone lengthening cm, min / max 1 / 14 35 / 35
FITBONE/ PRECICE nails 214 / 747 15 / 27
164 patients were unidentified regarding gender, and 158 patients 
regarding etiology. 
22 nails could not be differentiated between FITBONE or PRECICE. 
LLD: limb length discrepancy
Table 4. Severity grading of complications divided into specific 
numbers and percentages of lengthened segments and patients
 Severity grade of complications
 Factor I II IIIA IIIB Sum
Number of complications 113 146 45 28 332
Complications per segment, % 11 15 5 3 34
Complications per patient, % 14 19 6 4 42
Grading according to severity by Black et al. (2015). 
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tion risks. A few possible risk factors for complications could 
be estimated at a study group level. We found 31% complica-
tions per segment for the PRECICE nail and 46% complica-
tions per segment for the FITBONE nail. Surgical unit experi-
ence was assessed by dividing studies into studies with less 
than 20 patients (49% complications per segment) and studies 
with more than 40 patients (30% complications per segment) 
(see Supplementary data 6 for studies included in sub-analysis 
and Supplementary data 7 for full data presentation).
The inter-rater agreement between the 2 assessors of com-
plications was 0.87 for severity grading and 0.94 for categori-
zation of origin. 
Discussion
To our knowledge, this is the first systematic review on com-
plications related to bone lengthening nails. The primary out-
come was the risk of type IIIB complications resulting in a new 
pathology or permanent sequelae. This review found such IIIB 
complications in 3% of lengthened segments. Furthermore, a 
complication of any type was found in 34% of lengthened 
segments, and 5% of segments did not achieve the planned 
lengthening due to a complication (IIIA). In 15% of segments 
treated with intramedullary PRECICE and FITBONE length-
ening nails, a complication (II) resulted in substantial change 
in treatment, such as unplanned re-surgery. 6% (11/177) of 
time-determined complications occurred intra- or periopera-
tively prior to start of distraction, and 94% of complications 
(166/177) occurred during or after the end of distraction. The 
high diversity of complications demonstrates that several 
means must be applied to reduce the high number of compli-
cations in intramedullary bone lengthening. Concerning the 
primary outcome, where the (type IIIB) complication resulted 
in a new pathology or permanent sequelae, the majority of 
complications were a result of joint-related complications 
such as contracture, subluxation, or dislocation. It is likely that 
a reduction in joint-related complications is accomplished by 
improved patient selection and attention to soft-tissue release 
as well as individualized protocols for lengthening, temporary 
extraarticular screw arthrodesis, splints/orthoses, or physio-
therapy. The risk of joint subluxation and dislocation was 6 
and 1 per 1,000 segments, respectively. Joint contracture was 
seen in 5% (53/983) of the segments, and primary soft-tissue 
release might be a key to address this complication; this was, 
however, only reported in 5 of the 41 studies (Shabtai et al. 
2014, Paley et al. 2015, Laubscher et al. 2016, Rozbruch 2017, 
Calder et al. 2019). Calder et al. made a systematic division of 
the iliotibial band (ITB) if the planned lengthening was above 
3 cm. They found that, in femoral lengthening, females lost 
joint movement in the hip and knee earlier than males. More-
over, it took substantially more time to regain range of motion 
in patients treated with retrograde compared with antegrade 
nails. However, we believe that higher rates of severe joint 
Table 5. Complications categorized into 8 main groups (soft tissue, 
joint, vascular, bone, neurological, infection, device-related, others) 
and 33 subgroups
 Severity grade and origin of complications
Group I II IIIA IIIB Sum
Soft tissue
 Skin 2 1   3
 Muscles     0
 Tendons     0
 Pain 5    5
 Others 2 1   2 (CS) 5
Sum of soft tissue     13
Soft tissue complications in % of segments   1
Joint   
 Pain 1    1
 Contracture 19 24 5 5 53
 Subluxation    6 6
 Dislocation    1 1
 Others         0
Sum of joint     61
Joint complications % of segment:    6
Vascular  
 Vascular damage    1 1
 Deep vein thrombosis    4 4
 Hemorrhage/hematoma 2    2
 Others 2     1 (AV) 3
Sum of vascular     10
Vascular complications in % of segments:    1
Bone   
 Premature consolidation  15 4  19
 Delayed healing 16 27 2 1 46
 Secondary malalignment  1  2 3
 Fracture  6 1 1 8
 Others 1 1   2
Sum of bone     78
Bone complications in % of segments:    8
Neurology  
 Paresthesia 2 1 2  5
 Paralysis     0
 Others 3       3
Sum of neurology     8
Neurology complication in % of segments:    0.8
Infection  
 Superficial soft tissue 2 1   3
 Deep soft tissue  1   1
 Osteomyelitis   3 1 4
 Others         0
Sum of infection     8
Infection complications in % of segments:    0.8
Device-related   
 Distraction mechanism 16 20 9  45
 Mechanical strength 25 14 3 2 44
 Attachment failure 8 24 1  33
 Others       0
Sum of device-related     122
Device-related complications in % of segments:   12
Others    
 Patient   6  6
 Surgical  3 7 1 11
 Others    1  1
Sum of others     18
Others, complications in % of segments    1.8
CS: compartment syndrome; 
AV: arteriovenous fistula of the posterior tibial artery decompensated 
during tibial lengthening and an embolization procedure had to be 
performed. 14 complications could not be categorized due to missing 
descriptions.
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complications must be anticipated in high-risk patients such 
as congenital femoral deficiency and fibular hemimelia. We 
believe there is a need for systematic reporting of primary 
soft-tissue release as there is a lack of knowledge of benefits 
and challenges concerning this issue.
A device-related complication was seen in 12% (122/983) 
of segments with 5% (45/983) assigned to distraction mecha-
nism-related complications, and 1% (13/983) of segments did 
not reach the lengthening goal due to device-related type IIIA 
complications. The overall complication rate per segment was 
46% for studies only reporting the use of a FITBONE nail and 
31% for studies only reporting the use of a PRECICE nail. 
However, the quality of data is not sufficient to compare com-
plication rates between the 2 nail types; for example, did the 
studies that used only FITBONE nails include tibial length-
ening in 27% compared with 16% in the PRECICE studies. 
In addition, in the FITBONE group the average number of 
patients per study was only 13 compared with an average 
number of 28 patients per study in the PRECICE group. How-
ever, the relatively high rate of device-related complications 
shown in this review warrants a constant focus on the tech-
nology of bone lengthening nails. Future studies should spe-
cifically report the type and generation of the applied nail to 
assess complication risk related to different nails and genera-
tions.
Complications related to bone regeneration were mainly due 
to delayed healing in 5% (46/983) of segments or premature 
consolidation in 2% (19/983) of segments. These complica-
tions might be reduced by increasing knowledge and handling 
of nail stability, patient compliance, mobilization, and biologi-
cal factors such as type of osteotomy, latency period, and dis-
traction rate/force. Another solution might be providing real-
time feedback on surrogate markers of bone healing to allow 
for individualized distraction treatment. It seems logical that 
a surgeon’s ability to avoid or recognize, manage, and solve 
complications strongly correlates with the surgeon’s experi-
ence of this highly specialized treatment. This was to some 
extent supported by this review as studies with fewer than 20 
patients had more complications per segment compared with 
studies with more than 40 patients.
The validity of a review depends on the quality of the 
included studies and on the validity of the data extraction. The 
level of evidence in the studies included in this review was 
low. Of the 41 included studies, there were 1 level 3 study, 32 
level 4 studies, and 8 case reports and mean MINORS scores 
of about half of the ideal scores. Our study found 146 type II 
complications compared with 113 type I complications, and 
most patients thus had a more complex type of complication. 
This might reflect both underreporting and the lack of accurate 
reporting of complications in elective surgery (Martin et al. 
2002). 
We assessed complications in relation to segment lengthen-
ing and not to each patient because, in some patients, bone 
lengthening occurred in more than 1 bone in the same leg, 
lengthening involved both legs (short stature patients), and 
some patients underwent multiple lengthening procedures of 
the same bone. Complications per segment were lower than 
complications per patient, but since most of the patients had 
lengthening of only one segment, segment was chosen for 
main reporting. 
41 studies with 983 bone lengthening segments reported 
either complications or stated absence of complications. With 
the increased popularity of lengthening by PRECICE and 
FITBONE nails, there is a knowledge gap concerning the dis-
tribution of severity grade and origin of complications in all 
treated patients. We believe that the demographics and number 
of included patients in this review are sufficiently diverse to 
illuminate even rare complications.
4 different classifications for reporting severity in bone 
lengthening complications were used (Paley 1990, Dahl et al. 
1994, Dinçyürek et al. 2012, Black et al. 2015), and 29 stud-
ies did not use a classification. We are familiar with at least 
4 more classifications of complications in limb lengthening, 
which challenges comparison between reported complica-
tions (Caton et al. 1985, Popkov 1991, Donnan et al. 2003, 
Lascombes et al. 2012). In this review we have classified the 
reported complications to achieve consistent reporting. How-
ever, it is a limitation that data on complications could be clas-
sified only from reported complications and not from original 
data. In the case of uncertainty between different grades of 
a complication, the complication was graded with the lower 
severity grade. Thereby, a systematic risk of reporting too low 
a complication severity grade was introduced. Another limita-
tion of our review is that the reported complication rates could 
not be specified on subgroup level. We would expect that the 
complication rates differ substantially between a patient with 
idiopathic lower limb lengthening undergoing 3 cm of simple 
antegrade femoral lengthening without deformity correction 
and a patient with congenital fibular hemimelia and multiple 
previous operations undergoing 5 cm of tibial lengthening. 
However, it was not possible to extract data on a single patient 
level from the current literature. Therefore, we could not make 
correlations between complication rates and individual risk 
factors. We encourage future studies to report complications 
on a single patient level where complications can be related 
to possible risk factors such as age, diagnosis/etiology, seg-
ment, approach, nail type nail, nail generation, and timing of 
complications.
Conclusion
This review of the literature shows an overall high rate of com-
plications, with complications occurring in 1 of every 3 seg-
ments undergoing lower limb lengthening. In 1 of every 4 seg-
ments, complications have a major impact leading to substan-
tial change in treatment (15%), failure to achieve lengthening 
goal (5%), or introduction of a new pathology or permanent 
sequelae (3%). As no standardized method of reporting com-
plications exists, the true complication rate might be different. 
Acta Orthopaedica 2021; 92 (1): 119–126 125
A standardized reporting method would substantially improve 
the knowledge needed to reduce the rate of complications.
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